| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/05/2011 | US7972602 Promiscuous HER-2/Neu CD4 T cell epitopes |
| 07/05/2011 | US7972601 Method of promoting delivery of an antioxidant agent to a cell expression neuroligin |
| 07/05/2011 | US7972600 IGF-IR antagonists as adjuvants for treatment of prostate cancer |
| 07/05/2011 | US7972599 Immunomodulation of inflammatory conditions utilizing Follistatin-like protein-1 and agents that bind thereto |
| 07/05/2011 | US7972597 Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteins |
| 07/05/2011 | US7972596 Antibodies against vascular endothelial growth factor receptor-1 |
| 07/05/2011 | US7972594 Ablative immunotherapy |
| 07/05/2011 | CA2427475C Purification of hbv antigens for use in vaccines |
| 07/05/2011 | CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof |
| 07/05/2011 | CA2380066C Antitumor antibodies, proteins, and uses thereof |
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 07/05/2011 | CA2220133C Recombinant vesiculoviruses and their uses |
| 07/05/2011 | CA2210656C Receptor specific transepithelial transport of immunogens |
| 06/30/2011 | WO2011079283A1 Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same |
| 06/30/2011 | WO2011079260A2 Stabilized virus like particles having enhanced mucosal immunogenicity |
| 06/30/2011 | WO2011079185A1 Anti-bv8 antibodies and uses thereof |
| 06/30/2011 | WO2011078781A1 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof |
| 06/30/2011 | WO2011078590A2 Ultraviolet protection composition comprising a blt2 inhibitor |
| 06/30/2011 | WO2011078456A1 Human antibodies specifically binding to the hepatitis b virus surface antigen |
| 06/30/2011 | WO2011078332A1 Polypeptide modification method for purifying polypeptide multimers |
| 06/30/2011 | WO2011077371A1 Method for enhancing the expression of hpv l1 |
| 06/30/2011 | WO2011077309A2 Vaccine compositions |
| 06/30/2011 | WO2011077258A1 Streptavidin and biotin- based antigen delivery system |
| 06/30/2011 | WO2011077143A1 Transformation of commensal neisseria |
| 06/30/2011 | WO2011076932A1 Receptors of rspo2 and rspo3 |
| 06/30/2011 | WO2011076922A1 Anti-flt3 antibodies and methods of using the same |
| 06/30/2011 | WO2011076781A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | WO2011076683A1 Anti-her3 antibodies and uses thereof |
| 06/30/2011 | WO2011075823A1 Immunogenic compositions |
| 06/30/2011 | WO2011075822A1 Immunogenic compositions and related methods |
| 06/30/2011 | WO2011075789A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | WO2011054997A3 Monoclonal antibody that recognises the gapdh protein of candida famata |
| 06/30/2011 | WO2011054995A3 PROPHYLACTIC FLU VACCINES FROM VIRAL CAPSIDS OF BIRNAVIRUS CONTAINING THE M2e ANTIGEN OF THE FLU VIRUS |
| 06/30/2011 | WO2011043538A3 Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof |
| 06/30/2011 | WO2011031676A3 Depleting immunosuppressive monocytes within a mammal |
| 06/30/2011 | WO2011031438A3 Porcine torque teno virus vaccines and diagnosis |
| 06/30/2011 | WO2011028938A8 Methods for lowering serum cholesterol in a subject using inhibition of pcsk9 |
| 06/30/2011 | WO2010150982A3 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 06/30/2011 | WO2010146598A3 Stable, dried rotavirus vaccine, compositions and process for preparation thereof |
| 06/30/2011 | WO2010144797A3 Influenza vaccines with enhanced immunogenicity and uses thereof |
| 06/30/2011 | WO2010138194A3 Immunomodulatory agent-polymeric compounds |
| 06/30/2011 | US20110162115 Recombinant ndv antigen and uses thereof |
| 06/30/2011 | US20110162113 Antibodies |
| 06/30/2011 | US20110160145 Treatment of fine wrinkles with clostridia neurotoxins |
| 06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
| 06/30/2011 | US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
| 06/30/2011 | US20110159081 Vaccine |
| 06/30/2011 | US20110159080 Composition comprising liposome-entrapped doxorubicin and methods of administration |
| 06/30/2011 | US20110159075 Compositions and systems for forming crosslinked biomaterials and methods of preparation and use |
| 06/30/2011 | US20110159072 Controlled release matrix |
| 06/30/2011 | US20110159047 Stable powder formulations of alum-adsorbed vaccines |
| 06/30/2011 | US20110159043 Allogeneic vaccine and methods to synthesize same |
| 06/30/2011 | US20110159042 Pythium immunotherapy |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159040 Novel immunogens and methods for discovery and screening thereof |
| 06/30/2011 | US20110159039 Eliciting hcv-specific antibodies |
| 06/30/2011 | US20110159038 Drying process |
| 06/30/2011 | US20110159037 Methods of treating and protecting against human immunodeficiency virus |
| 06/30/2011 | US20110159036 MVA expressing modified HIV envelope, GAG, and POL genes |
| 06/30/2011 | US20110159035 S/o type transdermal immunizing agent |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159033 West nile virus vaccine |
| 06/30/2011 | US20110159032 Modified vaccinia virus ankara for the vaccination of neonates |
| 06/30/2011 | US20110159031 Vaccine to Influenza A Virus |
| 06/30/2011 | US20110159030 Mucosal combination vaccines for bacterial meningitis |
| 06/30/2011 | US20110159029 Measuring degree of polymerisation for meningococcal capsular saccharides that contain sialic acid |
| 06/30/2011 | US20110159028 Compositions and methods for diagnosing and treating urinary tract infections |
| 06/30/2011 | US20110159027 S. agalactiae antigens i & ii |
| 06/30/2011 | US20110159026 Compositions and methods of enhancing immune responses to flagellated bacterium |
| 06/30/2011 | US20110159025 Methods, agents and peptides for inducing an innate immune response in HIV vaccination |
| 06/30/2011 | US20110159024 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 06/30/2011 | US20110159023 Pd-1 antagonists and methods for treating infectious disease |
| 06/30/2011 | US20110159022 Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine |
| 06/30/2011 | US20110159021 Xbp1, cd138, and cs1 peptides |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110159017 Trytophan catabolism in cancer treatment and diagnosis |
| 06/30/2011 | US20110159016 Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders |
| 06/30/2011 | US20110159015 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | US20110159014 Anti-her2 antibody variants |
| 06/30/2011 | US20110159013 Anti-ADDL Antibodies and Uses Thereof |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110159011 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases |
| 06/30/2011 | US20110159010 Compositions and Methods for Decreasing Type III Deiodinase Activity to Modulate Adiposity and Blood Glucose Levels |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159008 Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase ALK |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159006 Use of anti-factor xi antibodies for prevention of thrombus formation |
| 06/30/2011 | US20110159005 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof |
| 06/30/2011 | US20110159004 Methods and Compositions for Preserving the Viability of Photoreceptor Cells |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110159002 Stabilized liquid egg material for extended shelf life |
| 06/30/2011 | US20110159001 CROSS-NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES TO SARS-CoV AND METHODS OF USE THEREOF |
| 06/30/2011 | US20110159000 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/30/2011 | US20110158999 Antagonists of protease activated receptor-1 (par1) |
| 06/30/2011 | US20110158998 Helminth antigen and immunotherapy |
| 06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
| 06/30/2011 | US20110158996 Von willebrand factor specific binders and methods of use therefor |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |